Skip to main content icon/video/no-internet

PIERO ANVERSA IS a distinguished investigator in the field of cardiovascular applications of stem cell research. His work contributed to a paradigm shift about cardiac physiology, strengthening the position that conceives of the heart as a self—renewing organ. He was born in Parma, Italy, in 1940. He gained his medical degree at the University of Parma in 1965, where he worked as assistant professor of pathology until 1980. In the early 1980s, he started his collaboration with the New York Medical College, where he was appointed professor of medicine in microbiology, immunology, and pathology. In 1985 Dr. Anversa permanently moved to United States, where he currently holds the office of director of the New York Medical College Cardiovascular Research Institute and vice chairman of the Department of Medicine.

Piero Anversa made a great effort to change the widespread conception of the heart as a terminally differentiated postmitotic organ, incapable of any sort of regeneration. One of the first observations that opened the way to such a deep revision of cardiac cellular homeostasis was the finding of male cells, endowed with a XY karyotype, in female hearts transplanted into male recipients. A deeper investigation of this heart chimerism phenomenon subsequently demonstrated a group of c—kit—positive cells, which can differentiate into myocytes, endothelial cells, and smooth muscle cells. This multipotent, clonogenic, and self—renewing cell population was proven to be a primitively cardiac sort of stem cell. Cardiac stem cells (CSCs) have been isolated from different species of mammalian hearts, including human ones. They are distributed into the myocardium along with supporting cells, forming stem cell niches. Such a peculiar micro—environment significantly interacts with CSCs, regulating their proliferative potential through junctional proteins and soluble mediators in a mostly unidentified manner. The origin of these stem cell pools has been a debated issue ever since the first observations of heart chimerism were made: A scrupulous analysis of mouse embryonic heart made by Eberhard and Jockusch provided the evidence that all resident CSCs are formed during embryonic life, whereas heart chimerism in sex—mismatched transplants can be explained by the migration of host cells from atrial remnants to the donor heart.

Regenerative Cardiology

Piero Anversa and his cardiovascular research team played a major role in regenerative cardiology not only in trying to figure out cardiac stem cell compartment features but also in attempting to translate such basic information regarding stem cell physiology into a novel and promising therapeutic strategy. The possibility of regenerating cardiac tissue through a cellular therapy has been first explored in mice by Dr. Anversa using lineage negative bone marrow cells (BMCs), a mixed population of cells composed of hematopoietic and mesenchymal stem cells, along with endothelial progenitors. In 2001 his team demonstrated that the injection of BMCs into infarcted myocardium can mend the ischémie lesion, and many following clinical trials performed on humans corroborated such beneficial effects, which have been interpreted as the consequence of a novel proliferation of myocytes and vascular structures mediated by BMCs' differentiation or the effect of a paracrine stimulation of CSCs mediated by the graft.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading